CVS Health Co. (NYSE:CVS) Shares Bought by Seizert Capital Partners LLC

Seizert Capital Partners LLC raised its stake in shares of CVS Health Co. (NYSE:CVS) by 3.5% during the third quarter, HoldingsChannel reports. The firm owned 463,819 shares of the pharmacy operator’s stock after purchasing an additional 15,811 shares during the quarter. Seizert Capital Partners LLC’s holdings in CVS Health were worth $29,165,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in CVS. Vaughan Nelson Investment Management L.P. grew its stake in CVS Health by 16.8% during the 3rd quarter. Vaughan Nelson Investment Management L.P. now owns 34,285 shares of the pharmacy operator’s stock valued at $2,156,000 after purchasing an additional 4,920 shares during the last quarter. Natixis Advisors LLC raised its stake in shares of CVS Health by 25.2% in the third quarter. Natixis Advisors LLC now owns 846,208 shares of the pharmacy operator’s stock worth $53,210,000 after purchasing an additional 170,566 shares during the last quarter. Mizuho Markets Americas LLC lifted its holdings in shares of CVS Health by 1,470.2% during the third quarter. Mizuho Markets Americas LLC now owns 1,396,464 shares of the pharmacy operator’s stock worth $87,810,000 after purchasing an additional 1,307,531 shares during the period. Valley Wealth Managers Inc. boosted its position in CVS Health by 33.3% in the third quarter. Valley Wealth Managers Inc. now owns 65,027 shares of the pharmacy operator’s stock valued at $4,089,000 after buying an additional 16,232 shares during the last quarter. Finally, Empowered Funds LLC increased its holdings in CVS Health by 52.5% in the 3rd quarter. Empowered Funds LLC now owns 209,682 shares of the pharmacy operator’s stock worth $13,185,000 after buying an additional 72,228 shares during the period. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Stock Down 3.4 %

CVS opened at $53.19 on Friday. The company has a market cap of $66.93 billion, a PE ratio of 13.50, a price-to-earnings-growth ratio of 0.92 and a beta of 0.55. CVS Health Co. has a twelve month low of $52.71 and a twelve month high of $83.25. The company has a 50-day moving average price of $59.23 and a 200 day moving average price of $58.66. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, beating the consensus estimate of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The firm had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. During the same period in the prior year, the company earned $2.21 EPS. The firm’s revenue was up 6.3% compared to the same quarter last year. Sell-side analysts expect that CVS Health Co. will post 5.48 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, November 1st. Investors of record on Monday, October 21st were given a dividend of $0.665 per share. The ex-dividend date of this dividend was Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a yield of 5.00%. CVS Health’s payout ratio is presently 67.51%.

Analysts Set New Price Targets

Several analysts have recently commented on CVS shares. Barclays dropped their price objective on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a report on Thursday, November 7th. Evercore ISI upped their price target on shares of CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a report on Tuesday, October 8th. Cantor Fitzgerald reiterated a “neutral” rating and set a $62.00 price objective on shares of CVS Health in a research note on Tuesday, October 1st. Wells Fargo & Company dropped their target price on CVS Health from $61.00 to $60.00 and set an “equal weight” rating on the stock in a report on Monday, November 4th. Finally, StockNews.com downgraded CVS Health from a “hold” rating to a “sell” rating in a report on Thursday. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat, CVS Health has an average rating of “Moderate Buy” and a consensus price target of $72.44.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.